维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Bodrogi"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial显示文摘	Bernard Escudier Anna Pluzanska Piotr Koralewski Alain Ravaud Sergio Bracarda Cezary Szczylik Christine Chevreau Marek Filipek Bohuslav Melichar Emilio Bajetta Vera Gorbunova Jacques-Olivier Bay Istvan Bodrogi Agnieszka Jagiello-Gruszfeld Nicola Moore	2007	The Lancet . 2007 (9605)2007，，：	2
2	Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer显示文摘	M. Gershanovich H. A. Chaudri D. Campos H. Lurie A. Bonaventura M. Jeffrey F. Buzzi I. Bodrogi H. Ludwig P. Reichardt N. O’Higgins G. Romieu P. Friederich M. Lassus	1998	Annals of Oncology1998，，6：	1
3	Cerebellar developmental venous anomalies with associated vascular pathology 显示文摘	Kovacs T Osztie E Bodrogi L	2007	Br J Neurosurg2007，21，2：	1
4	Effect of angiogenesis inhibitors on renal cellcarcinoma显示文摘	Bodrogi I		Magy 0nkol0070，51，2：	1
5	Capacity building for HTA implementation in middle-income countries: the case of Hungary显示文摘	Kalfi Z Bodrogi J Boncz I	2013	Value in Health Regional Issues2013，2，2：	1
6	Changes in Laboratory Parame- ters Indicating cell necrosis and dysfunction in asphyxiated neonates on moderate systemic hypothermia显示文摘	RoKa A Vasathelyi B Bodrogi E	2007	Acta Paediatr2007，96，8：	1
7	Cerebellar devel- opmental venous anomalies with associated vascular pa- thology 显示文摘	Kovacs T Osztie E Bodrogi L	2007	Br J Neurosurg2007，21，2：	1
8	Does therapeutic reference pricing always result in cost-con- tainment显示文摘	Kal6 Z Muszbek N Bodrogi J	2007	Health Policy2007，80，3：	1
9	Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial显示文摘	Bernard Escudier Anna Pluzanska Piotr Koralewski Alain Ravaud Sergio Bracarda Cezary Szczylik Christine Chevreau Marek Filipek Bohuslav Melichar Emilio Bajetta Vera Gorbunova Jacques-Olivier Bay Istvan Bodrogi Agnieszka Jagiello-Gruszfeld Nicola Moore	2007	The Lancet2007，，9605：	1
10	Ordinal scale based description of colour rendering 显示文摘	Bodrogi Peter Stefan Brtickner Tran Quoc Khanh	2011	Color Research & Application2011，36，4：	1
11	Comparison of pedicle subtraction and Smith-Petersen osteotomies in correcting thoracic kyphosis when closed with a central hook-rod construct显示文摘	Lewis SJ Goldstein S Bodrogi A	2014	Spine2014，39，15：	1
12	Critical care management of major hydrofluoric acid burns: a case report, review of the literature, and recommendations for therapy显示文摘	Martin W Dünser Markus ?hlbauer Josef Rieder Isabella Zimmermann Helmut Ruatti Anton H Schwabegger Florian Bodrogi Georg M Huemer Barbara E Friesenecker Andreas J Mayr Philipp Lirk	2004	Burns2004，，4：	1
13	Chromaticity contrast in visual search on the multi-colour user interface显示文摘	Bodrogi P	2003	Displays2003，24，2：	1
14	Does therapeutic reference pricing always result in cost-containment?The Hungarian evidence显示文摘	KAID Z MUSZBEK N BODROGI J BIDLO J	2007	Health Policy2007，80，3：	1
15	Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer显示文摘	J. Horti E. Juhasz Z. Monostori K. Maeda S. Eckhardt I. Bodrogi		0，，：	1
16	Long-term memory colors of korean and hungarian observers显示文摘	Tarczali T Park D Bodrogi P	2006	Color Research and Application2006，31，3：	1
17	Cerebellar developmental venous anomalies with associated vascular pathology显示文摘	Kovfics T Osztie E Bodrogi L	2007	Br J Neurosurg2007，21，：	1
18	Cerebellar venous anomalies with symptomatic vascular malformations显示文摘	Kovacs T Pajor P Bodrogi L	2002	Ideggyogy Sz2002，55，：	1
19	On the Use of the sRGB Colour Space显示文摘	REHAK R BODROGI P SCHANDA J	1999	Displays1999，20，4：	1
20	Expression of HER-2/neu in testicular tumors显示文摘	Mandoky L Geczi L Bodrogi I	2003	Anticancer Res2003，23，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示